Entero Therapeutics Inc (ENTO)

Feb 17, 2025

Entero Therapeutics Appoints Richard Paolone as CEO - citybiz

Feb 17, 2025

Feb 16, 2025

AzurRx BioPharma Receives Approximately $550,000 for its 2020 CIR (French Research Tax Credit) - Marketscreener.com

Feb 16, 2025

Feb 15, 2025

Entero Therapeutics names Richard Paolone interim CEO - MSN

Feb 15, 2025

Feb 14, 2025

Entero Therapeutics Appoints Richard Paolone as Interim CEO - TipRanks

Feb 14, 2025

Feb 14, 2025

Entero Therapeutics names Richard Paolone interim CEO By Investing.com - Investing.com South Africa

Feb 14, 2025

Feb 14, 2025

Entero Therapeutics Names Richard Paolone Interim CEO - MarketWatch

Feb 14, 2025

Feb 14, 2025

Entero Therapeutics Names Richard Paolone Interim CEO -February 14, 2025 at 04:25 pm EST - Marketscreener.com

Feb 14, 2025

Feb 14, 2025

Strategic Leadership Shift: M&A Expert Takes Helm at Entero TherapeuticsKey Details Revealed - StockTitan

Feb 14, 2025

Feb 11, 2025

Entero Therapeutics, Inc. announced that it has received $2 million in funding from 1396974 B.C. Ltd - Marketscreener.com

Feb 11, 2025

Feb 10, 2025

Entero Therapeutics Inc (ENTO) Shares Soar Above 1-Year High - The News Heater

Feb 10, 2025

Feb 09, 2025

Entero Therapeutics Appoints Three New Board Members - citybiz

Feb 09, 2025

Feb 07, 2025

Entero Therapeutics Gets $2 Million Revolving Loan, Appoints 3 New Board Members - Marketscreener.com

Feb 07, 2025

Feb 07, 2025

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members - The Manila Times

Feb 07, 2025

Feb 07, 2025

Entero Therapeutics Secures $2 Million Loan and Appoints New Board Members - Nasdaq

Feb 07, 2025

Feb 07, 2025

Entero Therapeutics, Inc. Announces Board Changes -February 07, 2025 at 03:22 pm EST - Marketscreener.com

Feb 07, 2025

Feb 07, 2025

Major Board Shakeup at Entero Therapeutics as $2M Financing Deal Forces Director Changes - StockTitan

Feb 07, 2025

Feb 06, 2025

Entero Therapeutics Announces Board of Directors Restructuring - TipRanks

Feb 06, 2025

Feb 03, 2025

AzurRx BioPharma Announces Results of Phase IIa Trial of MS1819-SD in Exocrine Pancreatic Insufficiency - Marketscreener.com

Feb 03, 2025

Jan 14, 2025

Entero Therapeutics faces Nasdaq delisting over meeting lapse By Investing.com - Investing.com Australia

Jan 14, 2025

Jan 13, 2025

Entero Therapeutics faces Nasdaq delisting over meeting lapse - Investing.com

Jan 13, 2025

Jan 08, 2025

Entero therapeutics CFO sells $465 in stock - Investing.com

Jan 08, 2025

Dec 07, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SUM, STAF, ALVR, ENTO on Behalf of Shareholders - The Malaysian Reserve

Dec 07, 2024

Dec 06, 2024

$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of SUM, ENTO, ALVR and STAF - GlobeNewswire Inc.

Dec 06, 2024

Dec 04, 2024

ENTO (Entero Therapeutics) Price-to-Operating-Cash-Flow : (As of Dec. 04, 2024) - GuruFocus.com

Dec 04, 2024

Dec 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Dec 04, 2024

Dec 04, 2024

First Wave BioPharma, Inc. announced that it expects to receive $4 million in funding - Marketscreener.com

Dec 04, 2024

Nov 29, 2024

Deal Watch: Sarepta Targets RNAi In Broad Collaboration With Arrowhead - Citeline News & Insights

Nov 29, 2024

Nov 28, 2024

Entero Therapeutics faces financial obligations acceleration By Investing.com - Investing.com Nigeria

Nov 28, 2024

Nov 28, 2024

Entero Therapeutics faces financial obligations acceleration - Investing.com India

Nov 28, 2024

Nov 27, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAF, ATSG, ENTO, AVTE on Behalf of Shareholders - Marketscreener.com

Nov 27, 2024

Nov 22, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders - The Malaysian Reserve

Nov 22, 2024

Nov 21, 2024

Finansavisen - Finansavisen

Nov 21, 2024

Nov 19, 2024

Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight - PR Newswire

Nov 19, 2024

Nov 16, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire

Nov 16, 2024

Nov 15, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - AccessWire

Nov 15, 2024

Nov 14, 2024

ENTERO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Entero Therapeutics, Inc.ENTO - Marketscreener.com

Nov 14, 2024

Nov 14, 2024

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum - The Manila Times

Nov 14, 2024

Nov 14, 2024

Entero Therapeutics announces proposed reverse merger with Journey Therapeutics - TipRanks

Nov 14, 2024

Nov 14, 2024

Entero finds lifeline in reverse merger with nano-immunoconjugate firm Journey - FirstWord Pharma

Nov 14, 2024

Nov 13, 2024

Ademi LLP Investigates Whether Entero Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Nov 13, 2024

Nov 13, 2024

Shareholder Alert: Ademi LLP Investigates Whether Entero Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - The Bakersfield Californian

Nov 13, 2024

Nov 13, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, LBRDA, PULM, ENTO on Behalf of Shareholders - The Malaysian Reserve

Nov 13, 2024

Nov 13, 2024

ENTO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Entero Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Nov 13, 2024